Middle and late MARPs reveal a decrease of microglial homeostatic functions affecting chemotaxis, cell migration and phagocytosis (e.g., CX3CR1, SYK, P2RY12, BIN2, TFEB and TFE3) and thus mark AD progression. This evidence concerns the gene TFEB and Alzheimer disease.